Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Taiwan, France, Austria launch Indigenous Tao music archive project
07/30/2025 09:48 PM - Cross-Strait
Taiwan decries Chinese coast guard 'harassment' off Kinmen
07/30/2025 09:35 PM - Society
Supreme Court upholds life sentence for man guilty of double homicide
07/30/2025 09:16 PM - Culture
Taiwan brings jazz and dance to George Town Festival
07/30/2025 08:49 PM - Culture
Taiwan National Railway Museum to open after nine years of restoration work
07/30/2025 08:37 PM